With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Saturating CRISPR gene body scans in MLL-rearranged leukemia||Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD & Lu Yang, PhD||Innovation Grants||2019||California|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||University of Southern California / Meenal Mehrotra, MD/PhD & Besim Ogretmen, MD/PhD||Innovation Grants||2019||California|
|Studying the clonal dynamics and evolution of leukemia using molecular barcodes||Lucile Packard Children's Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD||Innovation Grants||2011||California|
|Overcoming Obstacles to Drug Development in Pediatric Cancer||Stanford University School of Medicine / Crystal L. Mackall, MD||Crazy 8 Initiative||2019||California|
|Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma||University of California, San Diego / Alice Yu, MD, PhD||Innovation Grants||2011||California|
|Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford||Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D.||Phase I/II Infrastructure Grants||2015||California|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|
|Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).||University of California San Francisco / Michelle Hermiston, MD, PhD||Young Investigator Grants||2009||California|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|